For complex chronic wounds, time isn’t always the greatest healer. Get back on track when wounds fail to progress, using PICO sNPWT active therapy to help stimulate the healing process in non-healing wounds.1-3
Clinicians in the community already dedicate a substantial amount of time to managing chronic wounds,4 so wounds that fail to progress add to that workload. Wounds that remain in a prolonged inflammatory phase beyond 4-6 weeks should be addressed promptly to improve the chances of recovery. The longer you wait, the more challenging it becomes to heal.5
When incorporated into a clinical pathway, evidence shows why PICO sNPWT can be an incredibly powerful tool to help activate healing in stalled wounds.1-3
Living with a non-healing wound can deeply affect patients’ quality of life, from pain and sleep deprivation to social anxiety and isolation. Data highlights why the broader impact of non-healing wounds is such an enormous challenge. Flip the cards to reveal the problem.
If left unaddressed, the healing trajectory of non-healing wounds is unlikely to change…but clinical data has shown how the effective use of PICO sNPWT active therapy can help kick-start healing.
A lightweight, portable pump that delivers a consistent –80mmHg of negative pressure, with visual alerts for air leaks, low battery and dressing changes.
Developed to be pocket-sized and convenient, without the need for an exudate canister8 so patients have a greater sense of freedom while undergoing NPWT.9-12
Suitable for safe and effective use in outpatient settings as it is easy to apply and remove,9,13 and minimises the impact on patients' daily routines.1,2,9
Can be used with fillers on deep wounds and is compatible with compression therapy or adjuvant pressure garment therapy (PGT), such as hosiery or elastic garments following surgery.1,14,15
Regular-AIRLOCK Technology facilitates the consistent delivery of NPWT, even when put under pressure,***20,22,32 redistributing pressure over a larger contact area and delivering effective NPWT to more of the wound and peri-wound tissue than traditional NPWT (tNPWT) dressings.***20,22, 32-34
Shown to help provide better quality granulation tissue without filler than other NPWT systems with filler; producing granulation tissue that’s less inflammatory and allowing re-epithelisation to occur under the dressing.27,28,35
Removing PICO sNPWT resulted in less disruption to granulation tissue, when compared to tNPWT with filler. Furthermore, wounds treated with tNPWT with filler have been shown to have inflammatory cell activity.**27
The combined action of 80% evaporation and 20% absorption allows the PICO System to absorb exudate effectively, without the use of an external canister.22,30 Even if negative pressure is lost, wound model testing shows the PICO Dressing continues to manage exudate without leakage at the dressing edges.8,16 PICO sNPWT has been shown to help reduce the risk of maceration.1,18
Capable of managing low to moderate levels of exudate at wound depths of up to 4.5cm.16 In a variety of chronic wounds deeper than 2cm, PICO sNPWT resulted in a 46% relative reduction in mean time to wound healing (as part of an integrated care bundle, compared to standard dressings).9
Regular-AIRLOCK Technology facilitates the consistent delivery of NPWT, even when put under pressure,***20,22,32 redistributing pressure over a larger contact area and delivering effective NPWT to more of the wound and peri-wound tissue than traditional NPWT (tNPWT) dressings.***20,22, 32-34
Shown to help provide better quality granulation tissue without filler than other NPWT systems with filler; producing granulation tissue that’s less inflammatory and allowing re-epithelisation to occur under the dressing.27,28,35
Removing PICO sNPWT resulted in less disruption to granulation tissue, when compared to tNPWT with filler. Furthermore, wounds treated with tNPWT with filler have been shown to have inflammatory cell activity.**27
The combined action of 80% evaporation and 20% absorption allows the PICO System to absorb exudate effectively, without the use of an external canister.22,30 Even if negative pressure is lost, wound model testing shows the PICO Dressing continues to manage exudate without leakage at the dressing edges.8,16 PICO sNPWT has been shown to help reduce the risk of maceration.1,18
Capable of managing low to moderate levels of exudate at wound depths of up to 4.5cm.16 In a variety of chronic wounds deeper than 2cm, PICO sNPWT resulted in a 46% relative reduction in mean time to wound healing (as part of an integrated care bundle, compared to standard dressings).9
Early intervention with PICO sNPWTresultedin 94% of wounds being healed or a healing trajectory, demonstrated in wounds that were less than 3 months old. In contrast, the success rate dropped to 33% for wounds treated after 12 months.2
Achieving successful outcomes depends on early and accurate assessment, identification of wound aetiology and consideration of local and systemic factors that may be contributing to non-healing.
Evidence has demonstrated that healing success rates become gradually less favourable if active therapy is implemented after 3 months.2 Aim to follow a clinical pathway that facilitates early intervention on suitable patients.
Living with a diabetic foot ulcer can affect so many aspects of a patient’s life. As Kevin’s experience highlights, the PICO System’s ability to offer comfort, freedom and wound healing progress can be truly profound. As you listen to Kevin’s story, imagine the potential benefits for your patients.
When building an effective treatment pathway for non-healing wounds, experts like Rosemary Hill need the option of advanced technologies at their disposal. Listen to Rosemary explain how and why she uses PICO sNPWT’s active therapy to help put wounds on a healing trajectory.
| Dressing sizes | PICO 7 system | PICO 7 system | PICO 14 System | Multipack | PICO 7Y device |
| + 1 dressing | + 2 dressings | + 2 dressings | with 5 dressings | + 2 dressings | |
| Multisite small 15cm x 20cm | 66802010 | 66802000 | 66802040 | 66802020 | - |
| Multisite large 20cm x 25cm | 66802011 | 66802001 | 66802041 | 66802021 | 66802031 |
| 10cm x 20cm | 66802012 | 66802002 | 66802042 | 66802022 | - |
| 10cm x 30cm | 66802013 | 66802003 | 66802043 | 66802023 | - |
| 10cm x 40cm | 66802014 | 66802004 | 66802044 | 66802024 | - |
| 15cm x 15cm | 66802015 | 66802005 | 66802045 | 66802025 | - |
| 15cm x 20cm | 66802016 | 66802006 | 66802046 | 66802026 | - |
| 15cm x 30cm | 66802017 | 66802007 | 66802047 | 66802027 | - |
| 20cm x 20cm | 66802018 | 66802008 | 66802048 | 66802028 | - |
| 25cm x 25cm | 66802019 | 66802009 | 66802049 | 66802029 | - |
* DFU cases; n=4.
** n=161; ITt analysis; Least-Squared (LS) mean.
*** As demonstrated in benchtop testing.
**** 97% reduction in established biofilm bacteria; p<0.05. Demonstrated in vitro vs baseline. Tested against Pseudomonas aeruginosa, after 72-hour treatment with 1.49 Log10 CFU/ml reduction. 99% of bacteria locked in the dressing demonstrated in vitro.
Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.
Text